Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TN › Knoxville › NPI 1447769807

C a H Managment Company, LLC

C a H Managment Company, LLC was paid $9.81M by Medicaid between Apr 2018 and Dec 2024, across 22 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 46% of everything it billed.

33Billing provider infoC A H MANAGMENT COMPANY, LLC
KNOXVILLE, TN 37922
33aNPI1447769807assigned 09/28/2017
28Total paid$9.81M
24GClaims192,187
24DCodes billed22
24AFirst – last monthApr 2018 – Dec 2024
Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20183,512$182K
20198,952$437K
20207,580$395K
202128,807$1.64M
202250,311$2.27M
202352,262$2.60M
2024incomplete40,763$2.28M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 46% 62,898 58,032 $4.52M
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 30% 30,724 27,907 $2.92M
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 7.5% 30,461 27,834 $736K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 6.8% 11,760 11,055 $668K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 3.8% 5,202 4,842 $375K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2.8% 32,091 14,356 $277K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2.5% 8,495 7,415 $245K
87807 <1% 3,799 3,487 $31K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,035 1,781 $26K
87430 <1% 887 660 $7K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 560 503 $5K
71046 Radiologic examination, chest; 2 views <1% 327 292 $5K
10 more codes
87501 <1% 583 $2K
81002 <1% 471 $887.94
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 37 $581.07
87420 <1% 195 $521.52
81003 <1% 233 $383.81
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 664 $106.61
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 58 $76.33
94760 <1% 629 $65.34
94761 <1% 33 $19.97
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 45 $1.59

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGODBOLD, STEVEN (VP OF OPERSATIONS)